Interpace Diagnostics Group, Inc.(IDXG) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results PARSIPPANY, NJ, Nov 4, 2024 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCQX: IDXG) today announced financial results for the third quarter ended September 30, 2024 and provided a business and financial update. Third quarter Net Revenue was $12.3 million. Operating costs per test for the third quarter were approximately 11% lower than the same period of 2023. Income from ...